Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial
- Journal:
- The New England Journal of Medicine
- Published:
- Affiliations:
- 5
- Authors:
- 8
| Institutions | Authors | Share |
|---|---|---|
| Peking University First Hospital, PKUHSC, China | 0.38 | |
| RemeGen, Ltd., China | 0.31 | |
| University of New South Wales (UNSW Sydney), Australia | 0.13 | |
| Vor Biopharma, United States of America (USA) | 0.13 | |
| Tongji University, China | 0.06 |